144 related articles for article (PubMed ID: 34788927)
1. [Clinical efficacy and safety of flumatinib combined with multidrug chemotherapy in the treatment of 12 cases with Ph(+) acute lymphoblastic leukemia].
Mi RH; Chen L; Yang HP; Wei XL; Liu J; Yin QS; Zhang LN; Wei XD
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):858-861. PubMed ID: 34788927
[No Abstract] [Full Text] [Related]
2. [Clinical observation of flumatinib combined with induction chemotherapy and sequential allogeneic hematopoietic stem cell transplantation in the treatment of 6 patients with newly diagnosed Ph(+) acute lymphocytic leukemia].
Lian XY; Dai HP; Cui QY; Tang XW
Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):169-172. PubMed ID: 36948876
[No Abstract] [Full Text] [Related]
3. Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia.
Guan W; Jing Y; Dou L; Wang M; Xiao Y; Yu L
Leuk Lymphoma; 2020 Apr; 61(4):855-861. PubMed ID: 31755348
[TBL] [Abstract][Full Text] [Related]
4. Time to tune the treatment of Ph+ ALL.
Yanada M
Blood; 2015 Jun; 125(24):3674-5. PubMed ID: 26069331
[TBL] [Abstract][Full Text] [Related]
5. Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.
Chalandon Y; Thomas X; Hayette S; Cayuela JM; Abbal C; Huguet F; Raffoux E; Leguay T; Rousselot P; Lepretre S; Escoffre-Barbe M; Maury S; Berthon C; Tavernier E; Lambert JF; Lafage-Pochitaloff M; Lhéritier V; Chevret S; Ifrah N; Dombret H;
Blood; 2015 Jun; 125(24):3711-9. PubMed ID: 25878120
[TBL] [Abstract][Full Text] [Related]
6. Low-dose decitabine enhances chidamide-induced apoptosis in adult acute lymphoblast leukemia, especially for p16-deleted patients through DNA damage.
Shi P; Zhang L; Chen K; Jiang Z; Deng M; Zha J; Guo X; Li P; Xu B
Pharmacogenomics; 2017 Aug; 18(13):1259-1270. PubMed ID: 28745928
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of flumatinib and its two major metabolites in plasma of chronic myelogenous leukemia patients by liquid chromatography-tandem mass spectrometry.
Yang Y; Liu K; Zhong D; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():25-30. PubMed ID: 22472641
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study of 32 patients with adult Philadelphia chromosome-positive acute lymphoblastic leukemia].
Chen XY; Zheng YL; Chen YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1567-71. PubMed ID: 25543476
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
10. Combination of imatinib and cytarabine for the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia.
Morgensztern D; Rosado MF; Raez LE; Santos ES; Cassileth PA
Leuk Lymphoma; 2005 Feb; 46(2):297-8. PubMed ID: 15621818
[No Abstract] [Full Text] [Related]
11. Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapy.
Patel SB; Gojo I; Tidwell ML; Sausville EA; Baer MR
Leuk Lymphoma; 2011 Jul; 52(7):1211-4. PubMed ID: 21534873
[TBL] [Abstract][Full Text] [Related]
12. Optimal central nervous system prophylaxis in Philadelphia chromosome-positive acute lymphoblastic leukemia: collateral damage in the imatinib era?
Bassan R
Leuk Lymphoma; 2011 Jul; 52(7):1164-5. PubMed ID: 21612380
[No Abstract] [Full Text] [Related]
13. Successful treatment with imatinib combined with less intensive chemotherapy (vincristine and dexamethasone) as induction therapy in a very elderly patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Nishii K; Sakakura M; Tsukada T; Ryuu H; Katayama N
Int J Hematol; 2007 Apr; 85(3):273-4. PubMed ID: 17483068
[No Abstract] [Full Text] [Related]
14. Long-term imatinib maintenance therapy for adult Philadelphia positive acute lymphoblastic leukemia.
Guillet S; Hirsch P; Marzac C; Mohty M; Marie JP; Legrand O
Leuk Lymphoma; 2014 Nov; 55(11):2646-8. PubMed ID: 24491028
[No Abstract] [Full Text] [Related]
15. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
[TBL] [Abstract][Full Text] [Related]
16. [Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy].
Wang J; Huang X; Jiang B; Qin Y; Bao L; Jiang H; Chen H; Jia J; Yang S; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):120-5. PubMed ID: 24606652
[TBL] [Abstract][Full Text] [Related]
17. [Adult acute lymphoblastic leukemia: current therapies and future perspectives].
Hayakawa F
Rinsho Ketsueki; 2016 Mar; 57(3):230-7. PubMed ID: 27076233
[TBL] [Abstract][Full Text] [Related]
18. Acute lymphoblastic leukemia in infants.
Pui CH; Evans WE
J Clin Oncol; 1999 Feb; 17(2):438-40. PubMed ID: 10080582
[No Abstract] [Full Text] [Related]
19. [Acute lymphoblastic leukemia].
Hatta Y
Rinsho Ketsueki; 2014 Feb; 55(2):185-90. PubMed ID: 24598186
[No Abstract] [Full Text] [Related]
20. Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia.
Jeha S; Coustan-Smith E; Pei D; Sandlund JT; Rubnitz JE; Howard SC; Inaba H; Bhojwani D; Metzger ML; Cheng C; Choi JK; Jacobsen J; Shurtleff SA; Raimondi S; Ribeiro RC; Pui CH; Campana D
Cancer; 2014 May; 120(10):1514-9. PubMed ID: 24501014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]